This is a working overview of phase 2 trial, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-17. Anything still debated is marked as such rather than presented as settled.
Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Pharmacologically the compound activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP signaling contribute to glucose-dependent insulin release, delayed gastric emptying, and reduced appetite, while glucagon receptor activation is associated with increased energy expenditure and hepatic fat oxidation. The single-molecule design is intended to keep these activities in one peptide rather than combining separate agents. Relative activity at each receptor differs, and the balance between them is a central question in interpretation. The glucagon component is partly offset by incretin-mediated insulin secretion, an interaction that remains incompletely characterized.
Dissolution behavior depends on the amino acid sequence, the counterion content, and the buffer chosen. Many peptides disperse readily in water or mild aqueous buffers, while others require a small amount of organic co-solvent or a change in pH. Adsorption to plastic and glass surfaces can reduce the concentration of a solution over time, particularly at low concentrations. Filtration before analysis removes particulates, and aliquoting limits repeated freeze-thaw cycles that stress the material.
Research-grade peptide material is commonly supplied as a lyophilized powder, a form that limits degradation during transport and storage. Standard practice keeps such material cold and protected from light and moisture, with tighter conditions used for long-term archives. Once dissolved, solutions are generally considered less stable than the dry powder and are handled on shorter timescales. These established conventions derive largely from general peptide chemistry rather than from compound-specific evidence alone.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide of about 39 residues | Backbone derived from a GIP sequence |
| Molecular mass | Approximately 4.7 kDa | Peptide chain plus fatty diacid moiety |
| Receptor targets | GLP-1, GIP, glucagon | Unimolecular triple agonist |
| Typical storage temperature | 2 to 8 degrees Celsius | Protect from light; avoid repeated freeze-thaw |
| Common analytical method | LC-MS/MS | Used for plasma quantification and purity checks |
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. Chromatographic profiles reveal related impurities, truncated sequences, and oxidation products, while mass measurement confirms the expected molecular mass. Purity values for research material are typically reported as a percentage by peak area. Reference standards help calibrate retention behavior across instruments. Independent laboratories emphasize method suitability because results depend heavily on column chemistry, gradient, and detection wavelength. Batch-to-batch comparison relies on the same validated method.
Investigational peptide material is commonly distributed as a lyophilized powder in sealed vials. The solid form appears as a white to off-white cake or powder and is hygroscopic once opened. Peptides of this size are sensitive to moisture, repeated freeze-thaw cycles, and prolonged exposure to ambient light. Handling practices therefore emphasize desiccation, minimal vial opening, and cold storage. Working aliquots are often prepared to avoid repeatedly warming the bulk container.
In cold climates, these cockroaches may move indoors, seeking warmer environments and food. Cockroaches may enter houses via wastewater plumbing, underneath doors, or via air ducts or other openings in the walls, windows or foundation. Cockroach populations may be controlled through the use of glue board traps or insecticides. Glue board traps (also called adhesive or sticky traps) are made using adhesive applied to cardboard or similar material. Bait can be placed in the center or a scent may be added to the adhesive. Inexpensive glue board traps are normally placed in warm indoor locations readily accessible to insects but not likely to be encountered by people: underneath refrigerators or freezers, behind trash cans, etc. Covering any cracks or crevices through which cockroaches may enter, sealing food inside insect-proof containers, and quickly cleaning any spills or messes that have been made is beneficial. Another way to prevent an infestation is to thoroughly check any materials brought inside: cockroaches and their egg cases (ootheca) can be hidden inside or on furniture, or inside boxes, suitcases, grocery bags, etc. Upon finding an egg case, use a napkin to pick it up and then forcefully crush it; the resulting fluid leakage will then indicate the destruction of the eggs inside. Discard the napkin and the destroyed egg case as garbage.
== Notable alumni == Anoop Malhotra (Lt. General, Indian Army) Cyrus Addie Pithawalla (Maj. General, Indian Army), (Recipient of Ashok Chakra) Ashok Malhotra (Professor, University of British Columbia) Diptendu Choudhury (Air Marshal, Indian Air Force) Nikesh Arora (CEO, Palo Alto Networks, previously, President & COO of SoftBank Corp and SVP and Chief Business Officer, Google) Pawanexh Kohli (CEO, National Centre for Cold-chain Development cum Chief Advisor, Department of Agriculture & Farmers Welfare, GOI) Rakesh Sharma (film director, made Final Solution in 2003) Rini Simon Khanna (News Anchor) Vijay Shankar (Retd.) (Vice Admiral, Indian Navy) Mohana Singh Jitarwal (One of the first female fighter pilots of India.) Kavery Nambisan (Surgeon and writer) Subrahmanyam Jaishankar (Minister of External Affairs) Parvez Dewan (Indian Administrative Service J&K Cadre. Secretary, India Tourism) Kabir Sadanand (Movie Director and Producer) Ramon Chibb (Filmmaker) Mohammad Jawed (Member of Parliament, Kishanganj) Kabir Khan (film director) Aparna Sharma (model, actress)
=== Legacy and claims of responsibility === Multiple claims of responsibility have continued to be put forward years after the recovery of the pumpkin. In 1999, editor-in-chief of the school paper Farhad Manjoo received an anonymous tip which potentially explained how the prank was carried out, involving a climb up the spire of the tower and the use of duct tape. The May 2000 Graduation issue of the Cornell Daily Sun stated that the prank was carried out by one Cornell student ringleader and two other Ithacan accomplices. In the Cornell Chimes Newsletter, it was stated that a student from the University of Montana, "Rob", confessed to former Head Chimesmaster Courtney Kimball that they had placed the pumpkin; Atlas Obscura deemed this inauthentic, though Cornell historian Ryan Earle stated that this was "the best source for how it happened." One rumor also claimed that the prankster's identity was passed down through each university archivist. In 2017, 20 years following the placement of the first pumpkin atop the tower, Manjoo, then reporter at The New York Times, called the event "the greatest prank in Cornell history" and that there was "no downside" in the pranksters coming forward as "all of that has passed now. Now they're just legends." Evan Fay Earle, the university archivist in 2017, stated that the pumpkin "continue[d] to generate interest at Cornell and [in] the community". The website about the pumpkin was partially brought back online for the anniversary.
=== P53 and p73 === p53 and p73 are tumor suppressor proteins and their degradation is tightly regulated by ubiquitination. Recently it was shown that their degradation can also occur via an ubiquitin-independent process; NQO1 blocks p53 and p73 degradation in the presence of NADH and protects them from 20S proteasomal degradation. This protein-protein interaction between p53 and NQO1 was non-catalytic.
=== Maintenance of LTP === Along with helping to establish LTP, CaMKII has been shown to be crucial in maintaining LTP. Its ability to autophosphorylate is thought to play an important role in this maintenance. Administration of certain CaMKII blockers has been shown not only to block LTP but also to reverse it in a time-dependent manner.
Sources: en.wikipedia.org
Zverev is an all-court player and does not aim to be better on any surface in particular. He has said, "I feel like I can play on all surfaces. I've been to two finals or won tournaments on every single surface. I don't feel like I have to focus on one... I feel like I have good chances at all of them." Toni Nadal, the uncle and coach of Rafael Nadal, has praised his ability on hard courts in particular, saying, "His best surface is, in my eyes, the hard court, because he moves better than he does on clay." Six of Zverev's first ten titles came on hard courts, while the other four were on clay. As of 2024, he has yet to win a title on grass, but has reached two finals and defeated Federer on that surface. His best grass tournament remains Halle, in his home country. Zverev has the ability to serve-and-volley as well. His older brother Mischa is regarded as the biggest proponent of this playing style on the modern tour. Although Zverev does not employ this technique as often as his brother, he has shown it can be effective in big matches such as the Madrid Masters final against Dominic Thiem, a player who rarely comes to the net. Zverev's volley and overhead technique are regarded as some of his biggest weaknesses. Zverev was tall but skinny and not very muscular when growing up. His fitness trainer Jez Green has focused on making him stronger and set a goal for him to add 4 kilograms (8.8 lb) of muscle each year.
Until January 1918, the Free Cossacks of Ukraine were subordinate to the Ukrainian General Secretariat of Internal Affairs. With the beginning of the Ukrainian-Soviet War, their units were incorporated into the regular army. However, after a number of battles against the Bolsheviks, Free Cossacks were disarmed in compliance with orders of the German command, whose troops had occupied Ukraine in March–April 1918 after the Treaty of Brest-Litovsk. On 29 April 1918 Pavlo Skoropadskyi, the earlier leader of Free Cossacks, was proclaimed Hetman of Ukraine at a congress of the conservative All-Ukrainian Union of Landowners. This coup was backed by generals of German and Austrian armies which were occupying Ukraine at that time. The previously democratic Ukrainian People's Republic was replaced with the Hetmanate, the Central Rada and the Council of Ministers of the Ukrainian People's Republic were abolished, with all their powers, as well as command over the military, being transferred to Skoropadskyi, and private land ownership was reinstated. Local administration was entrusted to commissioners personally appointed by the hetman. To achieve legitimacy among the Ukrainian population, the Skoropadskyi styled his regime as a continuation of Ukrainian Cossack traditions of the 17-18th centuries. The hetman's government included representatives of old Cossack nobility (starshyna), most prominently Fedir Lyzohub (head of the Conucil of Ministers) and Dmytro Doroshenko (Minister of Foreign Affairs).
== Eukaryotic analogue == The complexity in bacterial responses appears to be in the number of proteins induced by oxidative stress. In mammalian cells, the number of proteins induced is small but the regulatory pathways are highly complex. The inducers of oxidative stress responses in bacteria appear to be either the oxidant itself or interaction of the oxidant with a cell component. Most mammalian cells exist in an environment where the oxygen concentration is constant, thus responses are not directly stimulated by oxidants. Rather, cytokines such as tumor necrosis factor, interleukin-1 or bacterial polysaccharides induce SOD synthesis and multigene responses. Recent work shows that superoxide is a strong tumor promoter that works by activation and induction growth-competence related gene products. Other factors involved in the antioxidant gene expression include an induction of calmodulin kinase by increase in Ca2+ concentrations. E. coli cells have revealed similarities to the aging process of higher organisms. The similarities include increased oxidation of cellular constituents and its target specificity, the role of antioxidants and oxygen tension in determining life span, and an apparent trade-off between activities related to reproduction and survival.
== Antimicrobial effect == Due to their catalytic activity, some serine proteases possess potent antimicrobial properties. Several in vitro studies have demonstrated the efficacy of some proteases in reducing virulence by cleaving viral surface proteins. Viral entry into host cells is mediated by the interaction of these surface proteins with the host cell. When these proteins are fragmented or inactivated on the viral surface, the viral entry is impaired, leading to a reduction in infectivity of a broad spectrum of pathologically relevant microorganisms like Influenza, hRSV and others.
Sources: en.wikipedia.org
== Etymology == William C. Boyd alone and then together with Elizabeth Shapleigh introduced the term "lectin" in 1954 from the Latin word lectus, "chosen" (from the verb legere, to choose or pick out).
== History == As early as the 15th century, some alchemists and naturalists were aware that ant hills give off an acidic vapor. The first person to describe the isolation of this substance (by the distillation of large numbers of ants) was English naturalist John Ray, in 1671. Ants secrete the formic acid for attack and defense purposes. Formic acid was first synthesized from hydrocyanic acid by French chemist Joseph Gay-Lussac. In 1855, another French chemist, Marcellin Berthelot, developed a synthesis from carbon monoxide similar to the process used today. Formic acid was long considered a chemical compound of only minor interest in the chemical industry. In the late 1960s, significant quantities became available as a byproduct of acetic acid production. It now finds increasing use as a preservative and antibacterial in livestock feed.
== Disease relevance == E3 ubiquitin ligases regulate homeostasis, cell cycle, and DNA repair pathways, and as a result, a number of these proteins are involved in a variety of cancers, including famously MDM2, BRCA1, and Von Hippel-Lindau tumor suppressor. For example, a mutation of MDM2 has been found in stomach cancer, renal cell carcinoma, and liver cancer (amongst others) to deregulate MDM2 concentrations by increasing its promoter's affinity for the Sp1 transcription factor, causing increased transcription of MDM2 mRNA. Several proteomics-based experimental techniques are available for identifying E3 ubiquitin ligase-substrate pairs, such as proximity-dependent biotin identification (BioID), ubiquitin ligase-substrate trapping, and tandem ubiquitin-binding entities (TUBEs).
In January 2010, at President Obama's request, Bush and Bill Clinton established the Clinton Bush Haiti Fund to raise contributions for relief and recovery efforts after the 2010 Haiti earthquake earlier that month. On May 2, 2011, President Obama called Bush, who was at a restaurant with his wife, to inform him that Osama bin Laden had been killed. The Bushes joined the Obamas in New York City to mark the tenth anniversary of the September 11, 2001, terrorist attacks. At the Ground Zero memorial, Bush read a letter that President Abraham Lincoln wrote to a widow who had lost five sons during the Civil War. On September 7, 2017, Bush partnered with former presidents Jimmy Carter, George H. W. Bush, Bill Clinton, and Barack Obama to work with One America Appeal to help the victims of Hurricane Harvey and Hurricane Irma in the Gulf Coast and Texas communities. Over the years, President Bush has had a good-natured friendship with Michelle Obama. "President Bush and I, we are forever seatmates because of protocol, and that's how we sit at all the official functions," Obama told the Today Show. "He's my partner in crime at every major thing where all the 'formers' gather. So we're together all the time." Bush famously passed mints to Obama during the McCain funeral in September 2018 and gave them to her again during the funeral of his father in December 2018.
== Adverse effects == Mild symptoms such as nausea, loss of appetite, dizziness, vomiting, headache, sore gums, or frequent urination are common with this medication. Life-threatening side effects such as thrombocytopenia, hemolytic anemia, leukemia and encephalopathy are extremely rare. Theoretically probenecid can increase the risk of uric acid kidney stones.
Sources: en.wikipedia.org
As of the mid-2020s retatrutide remains investigational and is not an approved medicine in the United States or the European Union. It has been supplied mainly to participants in clinical trials. Labels and availability can change, so regulatory listings should be checked directly.
Dual agonists act at the GLP-1 and GIP receptors, whereas retatrutide adds glucagon receptor activity on the same peptide. This third activity is the main structural and pharmacological distinction discussed in the literature. Direct head-to-head comparisons remain limited.
Reports usually give the study code LY3437943 alongside the name, the dose in milligrams, and the week at which an endpoint was measured. Percent body-weight change is the most frequent headline measure. Units and populations vary, so comparisons across reports require care.
Mass spectrometry provides a mass value that can be compared with the expected value, while peptide mapping examines fragmentation patterns. Together these techniques support identity claims better than a single measurement can.